INM (STOCKS)
InMed Pharmaceuticals Inc. Common Shares
$0.680800
-0.034800 (-4.86%)
Prev close: $0.715600
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric A. Adams
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.35M
- Employees
- 13
- P/E (TTM)
- -0.19
- P/B (TTM)
- 0.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
4
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.94 | $0.00 | +0.0000 | +0.00% |
|
Jun 2024 (Q2)
|
$-0.19 | $0.00 | +0.0000 | +0.00% |
|
Mar 2024 (Q1)
|
$-0.76 | $0.00 | +0.0000 | +0.00% |
|
Jun 2022 (Q4)
|
$-280.60 | $-111.10 | -169.5000 | -152.57% |
Financial Statements
| Revenues | $4.51M |
| Benefits Costs and Expenses | $12.17M |
| Cost Of Revenue | $3.17M |
| Costs And Expenses | $12.17M |
| Gross Profit | $1.34M |
| Operating Expenses | $9.22M |
| Depreciation and Amortization | $211.46K |
| Research and Development | $2.23M |
| Other Operating Expenses | $6.77M |
| Operating Income/Loss | -$4.71M |
| Income/Loss From Continuing Operations After Tax | -$7.66M |
| Income/Loss From Continuing Operations Before Tax | -$7.66M |
| Net Income/Loss | -$7.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.32 |
| Diluted Earnings Per Share | -$3.32 |
| Basic Average Shares | 5,222,598 |
| Diluted Average Shares | 5,222,598 |
| Assets | $11.19M |
| Current Assets | $8.79M |
| Cash | $7.00M |
| Inventory | $947.90K |
| Other Current Assets | $840.76K |
| Noncurrent Assets | $2.40M |
| Fixed Assets | $764.25K |
| Intangible Assets | $1.54M |
| Other Non-current Assets | $100.00K |
| Liabilities | $1.60M |
| Current Liabilities | $1.48M |
| Wages | $376.66K |
| Other Current Liabilities | $1.10M |
| Noncurrent Liabilities | $123.83K |
| Equity | $9.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.59M |
| Liabilities And Equity | $11.19M |
| Net Cash Flow From Operating Activities | -$7.42M |
| Net Cash Flow From Operating Activities, Continuing | -$7.42M |
| Net Cash Flow From Investing Activities | -$3.54M |
| Net Cash Flow From Investing Activities, Continuing | -$3.54M |
| Net Cash Flow From Financing Activities | $10.96M |
| Net Cash Flow From Financing Activities, Continuing | $10.96M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$7.66M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.66M |
| Other Comprehensive Income/Loss | $0.00 |